Current practice and preventive epilepsy treatment in tuberous sclerosis complex

Takeaway

  • The notion and practice of pre-seizure electroencephalography (EEG) monitoring and epilepsy prevention in tuberous sclerosis complex (TSC) is generally implemented in most surveyed centers, despite the lack of published clinical trial results.

Why this matters

  • TSC is a rare, multisystem disease resulting from inactivating mutations in TSC1 or TSC2, causing tumors to form in multiple organs, in addition to severe, drug-resistant epilepsy in 70-90% of affected children; for which there should be a standardized treatment approach.

  • Clinicians’ standardized use of EEG monitoring and epilepsy prevention highlights awareness that early monitoring and intervention is the optimal management strategy for patients with TSC, to reduce long-term disability risk and improve outcomes as far as possible.

International Medical Press is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by International Medical Press for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, International Medical Press recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of International Medical Press or the sponsor. International Medical Press assumes no liability for any material contained herein.